Doximity (NYSE:DOCS) Shares Climb 8% – What’s Next?

Shares of Doximity, Inc. (NYSE:DOCS) shot up 8% on Tuesday. The company traded as high as $34.01 and last traded at $33.9640. 1,256,274 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 3,965,258 shares. The stock had previously closed at $31.45.

Key Headlines Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity and Wolters Kluwer agreed to integrate trusted UpToDate clinical content into Doximity Ask, the company’s AI-powered clinical decision-support tool. The partnership could improve Ask’s usefulness and strengthen Doximity’s long-term competitive position with clinicians and health systems. Doximity and Wolters Kluwer partnership
• Positive Sentiment: An investment analysis characterized demand for AI-driven medical platforms as a potential long-term growth catalyst and maintained a bullish view of Doximity’s opportunity in healthcare technology. Doximity AI-driven platform analysis
• Neutral Sentiment: Doximity’s fair-value estimate was increased, but analysts remain divided over whether AI can accelerate growth enough to offset potential pressure on margins. The mixed outlook limits the significance of the valuation bump. Doximity fair value and analyst outlook
• Negative Sentiment: BofA Securities raised its price target to $23 from $20 but retained an Underperform rating, signaling that it still sees downside risk relative to the recent trading level. BofA Doximity price target
• Negative Sentiment: Multiple law firms publicized a pending securities class action and the November 16, 2026 lead-plaintiff deadline. The complaints allege that Doximity misrepresented revenue growth, market share and Newsfeed advertising practices while sales growth and net income were slowing. These are allegations, not established findings, but the litigation creates reputational, legal and potential financial risks. Doximity securities class action notice

Analyst Ratings Changes

Several brokerages have recently issued reports on DOCS. Bank of America reiterated an “underperform” rating and issued a $20.00 price target (down from $38.00) on shares of Doximity in a research note on Monday, June 29th. Evercore set a $35.00 price objective on Doximity in a research report on Tuesday, September 29th. Weiss Ratings raised Doximity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Truist Financial lifted their target price on Doximity from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Thursday, August 13th. Finally, Needham & Company LLC reissued a “buy” rating and set a $41.00 target price on shares of Doximity in a research note on Friday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $30.73.

Doximity Stock Up 0.9%

The company has a market cap of $6.00 billion, a P/E ratio of 36.65, a PEG ratio of 26.08 and a beta of 1.22. The firm’s 50 day moving average is $27.19 and its two-hundred day moving average is $23.83.

Doximity (NYSE:DOCS) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.13. The company had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%. Doximity’s revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.36 earnings per share. As a group, research analysts forecast that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Insider Activity

In other news, Director Timothy S. Cabral sold 7,500 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $39.11, for a total value of $293,325.00. Following the sale, the director directly owned 3,221 shares of the company’s stock, valued at approximately $125,973.31. This represents a 69.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,613 shares of the company’s stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $30.68, for a total transaction of $80,166.84. Following the completion of the sale, the chief accounting officer directly owned 101,432 shares in the company, valued at approximately $3,111,933.76. This represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 19,250 shares of company stock worth $613,855 in the last 90 days. 31.80% of the stock is owned by company insiders.

Hedge Funds Weigh In On Doximity

A number of hedge funds have recently bought and sold shares of DOCS. Versant Capital Management Inc boosted its position in Doximity by 1,176.9% during the third quarter. Versant Capital Management Inc now owns 1,826 shares of the company’s stock valued at $52,000 after acquiring an additional 1,683 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in Doximity by 59.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company’s stock worth $53,000 after acquiring an additional 695 shares during the period. Fortitude Family Office LLC raised its position in shares of Doximity by 31,271.4% in the 3rd quarter. Fortitude Family Office LLC now owns 2,196 shares of the company’s stock worth $62,000 after acquiring an additional 2,189 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Doximity by 111.0% in the 1st quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock worth $60,000 after acquiring an additional 1,347 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Doximity by 937.7% in the 1st quarter. EverSource Wealth Advisors LLC now owns 2,833 shares of the company’s stock worth $66,000 after acquiring an additional 2,560 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.